Mitochondrial damage results in a reversible increase in lysosomal storage material in lymphoblasts from patients with juvenile neuronal ceroid-lipofuscinosis (Batten Disease).
We have previously demonstrated reduced phospholipid fatty acid content in blood cells and cultured skin fibroblasts from patients with JNCL. This has led to an experimental treatment regimen consisting of dietary supplementation with polyunsaturated fatty acids (PUFAs). In order to study the effects of PUFA supplementation in vitro, we have developed a laboratory model based upon cultured lymphoblast cell lines. We have transformed lymphocytes from four JNCL patients in whom disease linkage to chromosome 16 was informative. Cells from patients and controls were cultured with and without antibiotic (50 micrograms/ml gentamycin) and with and without PUFA supplementation. None of the control cells demonstrated significant storage under any of the above conditions. In gentamycin treated cells, we observed that many of the mitochondria were damaged. In addition, cells from patients incubated with gentamycin demonstrated large accumulations of autofluorescent storage material. Disease cells grown in the presence of antibiotic and PUFAs did not demonstrate a significant accumulation of storage material; this suggests a direct relationship between mitochondrial damage and storage of autofluorescent material. Moreover, it appears that this storage (but not mitochondrial damage) is reversed by the addition of PUFAs.
Boriack
R L
RL
Children's Medical Center of Dallas, University of Texas Southwestern Medical Center, Dallas, USA.
Cortinas
E
E
Bennett
M J
MJ
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002478:Cells, Cultured; D002648:Child; D002885:Chromosomes, Human, Pair 16; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D006801:Humans; D008214:Lymphocytes / Q000473:pathology* / Q000648:ultrastructure; D008247:Lysosomes / Q000187:drug effects / Q000473:pathology* / Q000648:ultrastructure; D008928:Mitochondria / Q000187:drug effects / Q000473:pathology* / Q000648:ultrastructure; D009472:Neuronal Ceroid-Lipofuscinoses / Q000235:genetics / Q000378:metabolism / Q000473:pathology*
D000900:Anti-Bacterial Agents; D005231:Fatty Acids, Unsaturated